Abstract
Certain health insurers offer a free choice of providers and an identical copayment regardless of the provider. Others build networks and use selective contracting and financial incentives to channel policyholders to contracted suppliers. In the case of unregulated prices, we compare these two policies when the off-network medical service is not covered. We show how policy ranking depends on the characteristics of demand. If demand is linear, a for-profit insurer and a not-for-profit insurer obtain a higher profit and utility under selective contracting than under uniform reimbursement. In the constant elasticity case, these results do not hold. Insurers prefer uniform reimbursement while consumers are better off under selective contracting in both cases.
Acknowledgement
We thank an anonymous reviewer and the Editor in Chief for their very helpful comments. The usual disclaimer applies.
Taking Proposition 1 into account, providers’ profits and policyholders’ net utility are respectively given by
From the insurer’s point of view, the cost incurred and the total net utility are respectively given by
To prove that ΔV = V
s
− VB > 0 when
where Y < 0 if
The right-hand member of (12) is defined if c/(βρ) ≥ p2 > c/β and is positive when c > k. The left-hand member of (12) is positive if

Right and left-hand members of (12).
Moreover, the equilibrium solution must satisfy (10). When k s = k, this imply
Taking (12) and (13) into account, we must have
The equilibrium price is solution of (12). (12) is an implicit equation F(p2,c, k, β, ρ) = 0. For each value of ρ, ρ ∈ {1/2, 3/5, 7/10, 4/5, 9/10}, and β, β ∈ {1/2, 3/5, 7/10, 4/5, 9/10}, using the Mathematica computation program, we can obtain m expressions p2 = Root[F, m] representing the exact root of F(p2,c, k) = 0. Each root is a function of c and k and can be computed for any value of (c, k). Among the m roots, we select the root corresponding to a real value satisfying the constraints
whose Mathematica solution is given by
where #1 represents the first argument supplied to a pure function. For each couple (c, k), we obtain a value of p2. Replacing (14) in p1, we obtain p1(c, k) and we can calculate
Values of
c\k | 1 | 3 | 5 | 7 | 9 | 11 | 13 | 15 | 17 |
---|---|---|---|---|---|---|---|---|---|
2 | 58.97 | ||||||||
4 | 7.13 | 86.54 | |||||||
6 | 2.41 | 13.63 | 96.02 | ||||||
8 | 1.12 | 5.28 | 16.79 | 100.85 | |||||
10 | 0.61 | 2.73 | 6.90 | 18.71 | |||||
12 | 0.37 | 1.65 | 3.72 | 7.96 | 20.00 | ||||
14 | 0.24 | 1.09 | 2.31 | 4.40 | 8.73 | 20.93 | |||
16 | 0.16 | 0.76 | 1.56 | 2.78 | 4.91 | 9.31 | 21.64 | ||
18 | 0.11 | 0.56 | 1.12 | 1.91 | 3.15 | 5.31 | 9.76 | 22.19 | |
20 | 0.07 | 0.42 | 0.83 | 1.39 | 2.19 | 3.44 | 5.63 | 10.12 | 22.64 |
For any c and k < k′′,
References
Anderson, S., A. de Palma, and J.-F. Thisse. 1992. Discrete Choice Theory of Product Differentiation. Cambridge: MIT Press.10.7551/mitpress/2450.001.0001Search in Google Scholar
Barros, P. P., and X. Martinez-Giralt. 2008. “Selecting Health Care Providers: ‘Any Willing Provider’ vs. Negotiation.” European Journal of Political Economy 24 (2): 402–14, https://doi.org/10.1016/j.ejpoleco.2007.10.001.Search in Google Scholar
Berndt, E. R., T. G. McGuire, and J. P. Newhouse. 2011. “A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets.” Forum for Health Economics & Policy 14: 1–30, https://doi.org/10.3386/w16879.Search in Google Scholar
Bernheim, B., and M. Whinston. 1998. “Exclusive Dealing.” Journal of Political Economy 106 (1): 64–103, https://doi.org/10.1086/250003.Search in Google Scholar
Bes, R. E, E. C. Curfs, P. P. Groenewegen, and J. D. de Jong. 2017. “Selective Contracting and Channelling Patients to Preferred Providers: A Scoping Review.” Health Policy 121: 520–14, https://doi.org/10.1016/j.healthpol.2017.03.008.Search in Google Scholar
Boone, J. 2019. “Health Provider Networks with Private Contracts: Is There Under-treatment in Narrow Networks?” Journal of Health Economics 67: 102222, https://doi.org/10.1016/j.jhealeco.2019.102222.Search in Google Scholar
Boone, J., and C. Schottmüller. 2019. “Do Health Insurers Contract the Best Providers? Provider Networks, Quality and Costs.” International Economic Review 60 (3): 1209–47, https://doi.org/10.1111/iere.12383.Search in Google Scholar
Boonen, L. H. H. M., B. Donkers, and F. T. Schut. 2011. “Channeling Consumers to Preferred Providers and the Impact of Status Quo Bias: Does Type of Provider Matter?” Health Services Research 46 (2): 510–30, https://doi.org/10.1111/j.1475-6773.2010.01196.x.Search in Google Scholar
Dixit, A., and J. E. Stiglitz. 1977. “Monopolistic Competition and Optimum Product Diversity.” The American Economic Review 67 (3): 297–308.Search in Google Scholar
Ellison, S. F., and C. M. Snyder. 2010. “Countervailing Power in Wholesale Pharmaceuticals.” The Journal of Industrial Economics 58 (1): 32–53, https://doi.org/10.1111/j.1467-6451.2010.00408.x.Search in Google Scholar
Gal-Or, E. 1997. “Exclusionary Equilibria in Health Care Markets.” Journal of Economics and Management Strategy 6 (1): 5–43, https://doi.org/10.1162/105864097567011.Search in Google Scholar
Martimort, D. 1996. “Exclusive Dealing, Common Agency and Multiprincipals Incentive Theory.” The RAND Journal of Economics 27 (1): 1–31, https://doi.org/10.2307/2555790.Search in Google Scholar
McGuire, T. G. 2012. “Demand for Health Insurance.” In Handbook of Health Economics, Vol. 2, edited by M. Pauly, T. G. McGuire, and P. P. Barros, 317–96. Amsterdam: Elsevier.Search in Google Scholar
Mougeot, M., and F. Naegelen. 2018. “Medical Service Provider Networks.” Health Economics 27: 1201–17, https://doi.org/10.1002/hec.3769.Search in Google Scholar
Siciliani, L., M. Chalkley, and H. Gravelle. 2017. “Policies towards Hospital and GP Competition in Five European Countries.”Health Policy 121: 103–10, https://doi.org/10.1016/j.healthpol.2016.11.011.Search in Google Scholar
Sinaiko, A. D. 2011. “How Do Quality Information and Cost Affect Patient’s Choice of Provider in a Tiered Network Setting? Results from a Survey.” Health Services Research 46 (2): 437–56, https://doi.org/10.1111/j.1475-6773.2010.01217.x.Search in Google Scholar
Singh, N., and X. Vives. 1984. “Price and Quantity Competition in a Differentiated Duopoly.” The RAND Journal of Economics 15 (4): 546–54, https://doi.org/10.2307/2555525.Search in Google Scholar
Spence, M. 1976a. “Product Differentiation and Welfare.” The American Economic Review 66 (2): 407–14.Search in Google Scholar
Spence, M. 1976b. “Product Selection, Fixed Costs and Monopolistic Competition.” The Review of Economic Studies 43 (2): 217–35, https://doi.org/10.2307/2297319.Search in Google Scholar
Vives, X. 2000. Oligopoly Pricing: Old Ideas and New Tools. Cambridge: MIT Press.Search in Google Scholar
Zweifel, P., F. Breyer, and M. Kifmann. 2009. Health Economics. New York: Springer.10.1007/978-3-540-68540-1Search in Google Scholar
© 2022 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Articles
- Health Care Provider Networks: Are Insurers Better Off?
- Multimarket Contact and Profitability Implications for US Airlines
Articles in the same Issue
- Frontmatter
- Articles
- Health Care Provider Networks: Are Insurers Better Off?
- Multimarket Contact and Profitability Implications for US Airlines